Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QRFPR | Q96P65 | 5/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | GHSR | Q92847 | 3/20 | 0.46 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.46 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.46 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29313314 | 1.00 | QRFPR (0.49) | QRFPROPRK1BCL2L1GHSRIL23R | |
| SCHEMBL27273355 | 0.91 | QRFPR (0.48) | QRFPRBCL2L1GHSRIL23ROPRL1 | |
| SCHEMBL29311915 | 0.90 | KEAP1 (0.50) | QRFPROPRK1 | |
| SCHEMBL29311988 | 0.90 | KEAP1 (0.50) | QRFPROPRK1 | |
| SCHEMBL29313808 | 0.88 | OPRK1 (0.48) | QRFPROPRK1 | |
| SCHEMBL29311903 | 0.86 | OPRD1 (0.51) | OPRK1 | |
| SCHEMBL29312019 | 0.86 | OPRD1 (0.51) | OPRK1 | |
| SCHEMBL21320398 | 0.86 | CHRNA1 (0.49) | QRFPROPRK1CALCRL | |
| SCHEMBL27272159 | 0.85 | CHRNA1 (0.46) | QRFPRBCL2L1GHSRIL23RCALCRL | |
| SCHEMBL29312038 | 0.84 | CTSB (0.61) | OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | QRFPR 488/4885OPRK1 3053/4885BCL2L1 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.